Tweaking Structure Can Impact Crystallization
A small change to a peptoid that crystallizes in one step (left) sends the modified peptoid down a more complicated path from disordered clump to crystal (right). CREDIT: Jim De Yoreo/PNNL
Silky chocolate, better drugs for treatment, or solar panels all require the same thing: just the right crystals making up the material. Now, scientists trying to understand the paths crystals take as they form have been able to influence that path by modifying the starting ingredient.
The insights gained from the results could eventually help scientists better control the design of a variety of products for energy or medical technologies.
"The findings address an ongoing debate about crystallization pathways," said materials scientist Jim De Yoreo at the Department of Energy's Pacific Northwest National Laboratory and the University of Washington. "They imply you can control the various stages of materials assembly by carefully choosing the structure of your starting molecules."
From Floppy to Stiff
One of the simplest crystals, diamonds are composed of one atom — carbon. But in the living world, crystals, like the ones formed by cocoa butter in chocolate or ill-formed ones that cause sickle cell anemia, are made from molecules that are long and floppy and contain a lengthy well-defined sequence of many atoms. They can crystallize in a variety of ways, but only one way is the best. In pharmaceuticals, the difference can mean a drug that works versus one that doesn't.
Chemists don't yet have enough control over crystallization to ensure the best form, partly because chemists aren't sure how the earliest steps in crystallization happen. A particular debate has focused on whether complex molecules can assemble directly, with one molecule attaching to another, like adding one playing card at a time to a deck. They call this a one-step process, the mathematical rules for which scientists have long understood.
The other side of the debate argues that crystals require two steps to form. Experiments suggest that the beginning molecules first form a disordered clump and then, from within that group, start rearranging into a crystal, as if the cards have to be mixed into a pile first before they could form a deck. De Yoreo and his colleagues wanted to determine if crystallization always required the disordered step, and if not, why not.
Clump, Snap and ...
To do so, the scientists formed crystals from a somewhat simplified version of the sequence-defined molecules found in nature, a version they call a peptoid. The peptoid was not complicated — just a string of two repeating chemical subunits (think "ABABAB") — yet complex because it was a dozen subunits long. Based on its symmetrical chemical nature, the team expected multiple molecules to come together into a larger structure, as if they were Lego blocks snapping together.
In a second series of experiments, they wanted to test how a slightly more complicated molecule assembled. So, the team added a molecule onto the initial ABABAB... sequence that stuck out like a tail. The tails attracted each other, and the team expected their association would cause the new molecules to clump. But they weren't sure what would happen afterwards.
The researchers put the peptoid molecules into solutions to let them crystallize. Then the team used a variety of analytical techniques to see what shapes the peptoids made and how fast. It turns out the two peptoids formed crystals in very different fashions.
A Tail of Two Steps
As the scientists mostly expected, the simpler peptoid formed initial crystals a few nanometers in size that grew longer and taller as more of the peptoid molecules snapped into place. The simple peptoid followed all the rules of a one-step crystallization process.
But thrusting the tail into the mix disrupted the calm, causing a complex set of events to take place before the crystals appeared. Overall, the team showed that this more complicated peptoid first clumped together into small clusters unseen with the simpler molecules.
Some of these clusters settled onto the available surface, where they sat unchanging before suddenly converting into crystals and eventually growing into the same crystals seen with the simple peptoid. This behavior was something new and required a different mathematical model to describe it, according to the researchers. Understanding the new rules will allow researchers to determine the best way to crystallize molecules.
"We were not expecting that such a minor change would make the peptoids behave this way," said De Yoreo. "The results are making us think about the system in a new way, which we believe will lead to more predictive control over the design and assembly of biomimetic materials."
This article has been republished from materials provided by DOE/Pacific Northwest National Laboratory. Note: material may have been edited for length and content. For further information, please contact the cited source.
De Yoreo et al. ‘Tuning crystallization pathways through sequence-engineering of biomimetic polymers.’ Nature Materials (2017), DOI: 10.1038/nmat4891.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018